Transcatheter Aortic Valve Replacement (TAVR) Double Balloon Valvuloplasty
Launched by COMMUNITY MEMORIAL HEALTH SYSTEM · Dec 28, 2021
Trial Information
Current as of June 07, 2025
Unknown status
Keywords
ClinConnect Summary
This clinical trial is studying a procedure called Transcatheter Aortic Valve Replacement (TAVR) for patients with a condition known as aortic valve stenosis, which means the heart's aortic valve is narrowed and doesn't open properly. The researchers want to see if performing a "double tap" technique—where the balloon used to open the valve is inflated twice instead of once—can help improve blood flow through the valve after the procedure. They believe that this extra inflation might lead to better results both right after the procedure and in the months that follow, without increasing the risk of complications.
To participate in this trial, individuals must be at least 18 years old, have severe narrowing of the aortic valve, and meet specific medical criteria to qualify for the TAVR procedure. Participants can expect to have their heart function monitored closely during and after the procedure to assess the impact of the double inflation technique. It's important to note that certain patients, such as those who have had previous heart valve surgery or have specific heart conditions, may not be eligible for this trial. Overall, this study aims to find ways to improve outcomes for patients undergoing this important heart procedure.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Male or female ≥18 years of age
- • 2. Diagnosis of severe native valve aortic stenosis
- • 3. Meets the standard of care indications to undergo TAVR procedure (aortic valve area \<1.0 cm2 or mean pressure gradient \>40 mmHg or peak velocity \>4.0 m/s or aortic valve area index \<0.6).
- • 4. Provided informed consent.
- Exclusion Criteria:
- • 1. History of prior aortic valve replacement
- • 2. Pre-existing moderate to severe aortic regurgitation
- • 3. Lacking pre-procedure echocardiogram
- • 4. Patients planning to undergo multiple valve replacements simultaneously
- • 5. Intraoperative arrhythmia
- • 6. Intraoperative hemodynamic instability
- • 7. Intraoperative complication during initial inflation (such as: aortic dissection, coronary artery occlusion, coronary artery dissection)
- • 8. At the discretion of the principal investigator, any reason that the potential subject may be unfit for participation, such as frailty.
About Community Memorial Health System
Community Memorial Health System (CMHS) is a leading healthcare provider dedicated to enhancing the health and well-being of the communities it serves. With a commitment to innovative patient care, CMHS conducts clinical trials that contribute to the advancement of medical knowledge and treatment options. Leveraging a multidisciplinary team of experienced healthcare professionals, CMHS facilitates research initiatives that prioritize patient safety, ethical standards, and rigorous scientific methodology. Through these efforts, CMHS aims to provide access to cutting-edge therapies and improve health outcomes, reinforcing its mission to deliver exceptional healthcare services to its diverse population.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ventura, California, United States
Patients applied
Trial Officials
Jennifer Wan, MD
Principal Investigator
Community Memorial HealthCenter
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials